Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Animal origin of 13th-century uterine vellum revealed using noninvasive peptide fingerprinting.

Fiddyment S, Holsinger B, Ruzzier C, Devine A, Binois A, Albarella U, Fischer R, Nichols E, Curtis A, Cheese E, Teasdale MD, Checkley-Scott C, Milner SJ, Rudy KM, Johnson EJ, Vnouńćek J, Garrison M, McGrory S, Bradley DG, Collins MJ.

Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):15066-71. doi: 10.1073/pnas.1512264112. Epub 2015 Nov 23.

2.

Probing linker design in citric acid-ciprofloxacin conjugates.

Milner SJ, Snelling AM, Kerr KG, Abd-El-Aziz A, Thomas GH, Hubbard RE, Routledge A, Duhme-Klair AK.

Bioorg Med Chem. 2014 Aug 15;22(16):4499-505. doi: 10.1016/j.bmc.2014.04.009. Epub 2014 Apr 15.

PMID:
24794750
3.

Probing bacterial uptake of glycosylated ciprofloxacin conjugates.

Milner SJ, Carrick CT, Kerr KG, Snelling AM, Thomas GH, Duhme-Klair AK, Routledge A.

Chembiochem. 2014 Feb 10;15(3):466-71. doi: 10.1002/cbic.201300512. Epub 2014 Jan 21.

PMID:
24449436
4.

Staphyloferrin A as siderophore-component in fluoroquinolone-based Trojan horse antibiotics.

Milner SJ, Seve A, Snelling AM, Thomas GH, Kerr KG, Routledge A, Duhme-Klair AK.

Org Biomol Chem. 2013 Jun 7;11(21):3461-8. doi: 10.1039/c3ob40162f. Epub 2013 Apr 11.

PMID:
23575952
5.

'He'll not talk to anyone': researching men on low incomes.

Mackereth C, Milner SJ.

Community Pract. 2009 Apr;82(4):24-7.

PMID:
19397080
6.

Synthesis of citrate-ciprofloxacin conjugates.

Md-Saleh SR, Chilvers EC, Kerr KG, Milner SJ, Snelling AM, Weber JP, Thomas GH, Duhme-Klair AK, Routledge A.

Bioorg Med Chem Lett. 2009 Mar 1;19(5):1496-8. doi: 10.1016/j.bmcl.2009.01.007. Epub 2009 Jan 10.

PMID:
19179071
7.

'Fit for purpose' health impact assessment: a realistic way forward.

Milner SJ, Bailey C, Deans J.

Public Health. 2003 Sep;117(5):295-300.

PMID:
12909416
8.

Characteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis.

Forbes BE, Hartfield PJ, McNeil KA, Surinya KH, Milner SJ, Cosgrove LJ, Wallace JC.

Eur J Biochem. 2002 Feb;269(3):961-8.

9.

Linkers for improved cleavage of fusion proteins with an engineered alpha-lytic protease.

Lien S, Milner SJ, Graham LD, Wallace JC, Francis GL.

Biotechnol Bioeng. 2001 Aug 20;74(4):335-43.

PMID:
11410858
10.

How women receiving adjuvant chemotherapy for breast cancer cope with their treatment: a risk management perspective.

Cowley L, Heyman B, Stanton M, Milner SJ.

J Adv Nurs. 2000 Feb;31(2):314-21.

PMID:
10672088
11.

Probing the disulfide folding pathway of insulin-like growth factor-I.

Milner SJ, Carver JA, Ballard FJ, Francis GL.

Biotechnol Bioeng. 1999 Mar 20;62(6):693-703.

PMID:
9951525
12.

Optimization of the hydroxylamine cleavage of an expressed fusion protein to produce recombinant human insulin-like growth factor (IGF)-I.

Milner SJ, Thomas SM, Ballard FJ, Francis GL.

Biotechnol Bioeng. 1996 May 5;50(3):265-72.

PMID:
18626954
13.
14.

Purification and characterization of S1 mutants of alpha-lytic protease having altered catalytic properties.

Haggett KD, Graham LD, Milner SJ, Whittaker RG.

Arch Biochem Biophys. 1994 Oct;314(1):132-41.

PMID:
7944385
16.

Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency.

Francis GL, Ross M, Ballard FJ, Milner SJ, Senn C, McNeil KA, Wallace JC, King R, Wells JR.

J Mol Endocrinol. 1992 Jun;8(3):213-23.

PMID:
1378742
17.

Does scrotal ultrasound reduce the need for orchidectomy in the clinically malignant testis?

Milner SJ, Blease SC.

Br J Radiol. 1990 Apr;63(748):263-5.

PMID:
2189527

Supplemental Content

Loading ...
Support Center